You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

PROMETHEGAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Promethegan, and when can generic versions of Promethegan launch?

Promethegan is a drug marketed by Cosette and is included in one NDA.

The generic ingredient in PROMETHEGAN is promethazine hydrochloride. There are twelve drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Promethegan

A generic version of PROMETHEGAN was approved as promethazine hydrochloride by ZYDUS PHARMS USA on November 18th, 2005.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PROMETHEGAN?
  • What are the global sales for PROMETHEGAN?
  • What is Average Wholesale Price for PROMETHEGAN?
Drug patent expirations by year for PROMETHEGAN
Drug Prices for PROMETHEGAN

See drug prices for PROMETHEGAN

Drug Sales Revenue Trends for PROMETHEGAN

See drug sales revenues for PROMETHEGAN

Recent Clinical Trials for PROMETHEGAN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shahid Beheshti UniversityPhase 3

See all PROMETHEGAN clinical trials

Pharmacology for PROMETHEGAN
Drug ClassPhenothiazine

US Patents and Regulatory Information for PROMETHEGAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette PROMETHEGAN promethazine hydrochloride SUPPOSITORY;RECTAL 087165-001 Aug 14, 1987 RX No Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.